72064-0210 GAVRETO - CanMED: NDC

Product NDC:

72064-0210

Brand Name:

GAVRETO

Generic Name:

pralsetinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: PRALSETINIB

Strength: 100.0

Unit: mg/1

Packages:

Code: 72064-0210-12

Description: 120 CAPSULE in 1 BOTTLE, PLASTIC (72064-210-12)

Effective Date: Sept. 4, 2020

Discontinued: April 30, 2022

Code: 72064-0210-60

Description: 60 CAPSULE in 1 BOTTLE, PLASTIC (72064-210-60)

Effective Date: Sept. 4, 2020

Discontinued: April 30, 2022

Code: 72064-0210-90

Description: 90 CAPSULE in 1 BOTTLE, PLASTIC (72064-210-90)

Effective Date: Sept. 4, 2020

Discontinued: April 30, 2022

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

RET, DDR1, TRKC, FLT3, JAK1/2, TRKA, VEGFR2, PDGFRB, FGFR1

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox